ZA973664B - Hepatitis b monoclonal antibodies - Google Patents

Hepatitis b monoclonal antibodies

Info

Publication number
ZA973664B
ZA973664B ZA973664A ZA973664A ZA973664B ZA 973664 B ZA973664 B ZA 973664B ZA 973664 A ZA973664 A ZA 973664A ZA 973664 A ZA973664 A ZA 973664A ZA 973664 B ZA973664 B ZA 973664B
Authority
ZA
South Africa
Prior art keywords
hepatitis
monoclonal antibodies
monoclonal
antibodies
Prior art date
Application number
ZA973664A
Other languages
English (en)
Inventor
Richard Seaton Tedder
Samreenljaz
Ruth Bridget Ferns
Original Assignee
Murex Diagnostics Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Murex Diagnostics Corp filed Critical Murex Diagnostics Corp
Publication of ZA973664B publication Critical patent/ZA973664B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/082—Hepadnaviridae, e.g. hepatitis B virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
ZA973664A 1996-04-25 1997-04-25 Hepatitis b monoclonal antibodies ZA973664B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9608626.9A GB9608626D0 (en) 1996-04-25 1996-04-25 Hepatitis b monoclonal antibodies

Publications (1)

Publication Number Publication Date
ZA973664B true ZA973664B (en) 1998-08-20

Family

ID=10792667

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA973664A ZA973664B (en) 1996-04-25 1997-04-25 Hepatitis b monoclonal antibodies

Country Status (10)

Country Link
US (1) US7393933B1 (fr)
EP (1) EP0904378B1 (fr)
JP (1) JP4118955B2 (fr)
AU (1) AU2645297A (fr)
CA (1) CA2252466C (fr)
DE (1) DE69738312T2 (fr)
ES (1) ES2297855T3 (fr)
GB (1) GB9608626D0 (fr)
WO (1) WO1997040164A1 (fr)
ZA (1) ZA973664B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL118626A0 (en) * 1996-06-11 1996-10-16 Xtl Biopharmaceuticals Limited Anti HBV antibody
EP0948533A1 (fr) * 1996-12-30 1999-10-13 Innogenetics N.V. Polypeptides de liaison a l'annexine v derives de l'hbsag et utilisation de ces dernieres
EP1111388A1 (fr) * 1999-12-23 2001-06-27 Universiteit Gent Interaction entre le CD14 et les composants de VHB
JP4772199B2 (ja) * 2000-03-31 2011-09-14 オーソ−クリニカル・ダイアグノスティックス・インコーポレイテッド 新規なｂ型肝炎ウイルス
FR2815634B1 (fr) * 2000-10-20 2003-10-31 Biomerieux Sa Anticorps monoclonaux diriges contre des virus de l'hepatite b
DE10339927A1 (de) * 2003-08-29 2005-03-24 Rhein Biotech Gesellschaft für neue Biotechnologische Prozesse und Produkte mbH Zusammensetzung zur Prophylaxe/Therapie von HBV-Infektionen und HBV-vermittelten Erkrankungen
PT1766098E (pt) * 2004-06-07 2014-08-22 Novartis Vaccines & Diagnostic Anticorpos monoclonais de coelho para antigénios de superfície da hepatite b e métodos para utilizar os mesmos
US20110097270A1 (en) * 2005-01-14 2011-04-28 Schofield Darren J Monoclonal Antibodies That Bind or Neutralize Hepatitis B Virus
JP4948783B2 (ja) 2005-05-18 2012-06-06 シスメックス株式会社 抗ＨＢｓモノクローナル抗体
WO2008053901A1 (fr) * 2006-10-30 2008-05-08 Advanced Life Science Institute, Inc. Procédé d'analyse de l'antigène s du virus de l'hépatite b
JP6882184B2 (ja) * 2015-03-25 2021-06-02 アイジーエム バイオサイエンシズ インコーポレイテッド 多価ｂ型肝炎ウイルス抗原結合分子およびその使用
WO2017059878A1 (fr) * 2015-10-07 2017-04-13 Humabs Biomed Sa Anticorps neutralisant puissamment le virus de l'hépatite b et utilisations de ces derniers
WO2018184593A1 (fr) * 2017-04-07 2018-10-11 厦门大学 Anticorps pour traiter une infection par l'hépatite b et maladie associée
KR102084912B1 (ko) * 2019-01-17 2020-03-05 주식회사 녹십자 B형 간염 바이러스 표면 항원의 입체 에피토프 및 이에 특이적으로 결합하는 항체
CN111659355B (zh) * 2020-06-23 2022-12-13 武汉瑞法医疗器械有限公司 烷基化修饰的乙肝病毒免疫吸附剂及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL310699A1 (en) * 1993-03-24 1995-12-27 Imperial College Molecule specifically bonding itself with antigen determinant of escape mutation of hepatitis b
GB9401987D0 (en) * 1994-02-02 1994-03-30 Imperial College Modified nucleic acid

Also Published As

Publication number Publication date
DE69738312D1 (de) 2008-01-03
WO1997040164A1 (fr) 1997-10-30
JP2000509269A (ja) 2000-07-25
DE69738312T2 (de) 2008-10-02
EP0904378B1 (fr) 2007-11-21
ES2297855T3 (es) 2008-05-01
AU2645297A (en) 1997-11-12
EP0904378A1 (fr) 1999-03-31
CA2252466C (fr) 2010-04-06
GB9608626D0 (en) 1996-07-03
US7393933B1 (en) 2008-07-01
CA2252466A1 (fr) 1997-10-30
JP4118955B2 (ja) 2008-07-16

Similar Documents

Publication Publication Date Title
IL128406A0 (en) Monoclonal antibodies
PL311926A1 (en) Anti-alphav-integrinic monoclonal antibodies
GB9603256D0 (en) Antibodies
ZA959336B (en) Antibodies
ZA979185B (en) Anti-ErbB2 antibodies
EP1073464A4 (fr) Anticorps monoclonaux presentant une immunogenicite reduite
IL130143A0 (en) Humanized anti-CD11a antibodies
ZA973664B (en) Hepatitis b monoclonal antibodies
GB9412166D0 (en) Retargetting antibodies
HUP9800744A3 (en) Antibodies against fas-antigene
EP0977590A4 (fr) Anticorps monoclonaux humains
EP0909278A4 (fr) Immunoglobuline g liee a la nephropathie et anticorps contre celle-ci
HUP9901579A3 (en) Antibodies specific for alpha-d-integrin
GB9718911D0 (en) Monoclonal antibodies
ZA951113B (en) Tumor assosiated monoclonal antibody 123av16
GB9615027D0 (en) Monoclonal antibodies
GB9722944D0 (en) Hepatitis B virus monoclonal antibodies
GB9722943D0 (en) Hepatitis B virus monoclonal antibodies
AP9801381A0 (en) Anti-human mp52 monoclonal antibody
GB9415331D0 (en) Antibodies
IL134049A0 (en) Anti-cryptdin antibodies
GB9406222D0 (en) Huminised antibodies
GB9406243D0 (en) Antibodies
GB9406244D0 (en) Altered antibodies
GB9401597D0 (en) Altered antibodies